# Voyager Therapeutics, Inc.: Form 8-K, filed Feb 12, 2026

- Company: [Voyager Therapeutics, Inc.](/companies/vygr.md) (CIK 1640266)
- Form: 8-K
- Filed: 2026-02-12
- Accepted by EDGAR: Feb 12, 2026, 08:00 ET
- Period: 2026-02-09
- Accession: 0001104659-26-013897
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1640266/000110465926013897/tm266042d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1640266/000110465926013897/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1640266/000110465926013897/tm266042d1_8k.htm

Filed Feb 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-013897. Last ingested by Listed: Nov 5, 2026, 16:29 ET. No prices; not investment advice.